Small molecule inhibitors such as BPTES and CB-839 that are glutaminase (GLS) inhibitors, can lead to cell proliferation arrest and apoptosis in AML and BCR–ABL-positive CML cells (88, 89). Here, GLS is linked to chronic myelogenous leukemia, BCR-ABL1 positive.